A61K 9/2027
Obtained by reactions only involving carbon-to-carbon unsaturated bonds
Official title: {obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates}
A61K9/2027 (Obtained by reactions only involving carbon-to-carbon unsaturated bonds) appears on 2,324 US grants and 4,596 published applications in this corpus.
Search patents in A61K- Granted patents
- 2,324
- Published applications
- 4,596
- Assignees
- 1,468
- Inventors
- 7,151
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 2 | 0 |
| 1978 | 0 | 0 |
| 1979 | 5 | 0 |
| 1980 | 3 | 0 |
| 1981 | 6 | 0 |
| 1982 | 7 | 0 |
| 1983 | 8 | 0 |
| 1984 | 4 | 0 |
| 1985 | 8 | 0 |
| 1986 | 6 | 0 |
| 1987 | 11 | 0 |
| 1988 | 11 | 0 |
| 1989 | 14 | 0 |
| 1990 | 11 | 0 |
| 1991 | 14 | 0 |
| 1992 | 13 | 0 |
| 1993 | 12 | 0 |
| 1994 | 11 | 0 |
| 1995 | 9 | 0 |
| 1996 | 22 | 0 |
| 1997 | 23 | 0 |
| 1998 | 20 | 0 |
| 1999 | 16 | 0 |
| 2000 | 22 | 0 |
| 2001 | 47 | 22 |
| 2002 | 36 | 56 |
| 2003 | 48 | 111 |
| 2004 | 34 | 114 |
| 2005 | 20 | 118 |
| 2006 | 25 | 120 |
| 2007 | 23 | 150 |
| 2008 | 19 | 134 |
| 2009 | 27 | 140 |
| 2010 | 42 | 168 |
| 2011 | 56 | 171 |
| 2012 | 55 | 174 |
| 2013 | 97 | 179 |
| 2014 | 122 | 227 |
| 2015 | 131 | 288 |
| 2016 | 127 | 262 |
| 2017 | 168 | 268 |
| 2018 | 120 | 177 |
| 2019 | 104 | 223 |
| 2020 | 108 | 185 |
| 2021 | 115 | 240 |
| 2022 | 109 | 234 |
| 2023 | 108 | 233 |
| 2024 | 135 | 230 |
| 2025 | 115 | 207 |
| 2026 | 73 | 165 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Tableting of specific polymer stabilizers6 Oct 2026US 12,751,926 B2BASF SE
- Combination drug for the control and management of type 2 diabetes mellitus6 Oct 2026US 12,751,958 B2Laboratorios Silanes S.A. de C.V.
- Oral formulations and uses thereof29 Sep 2026US 12,746,229 B2Inventisbio Co., Ltd.
- Solid pharmaceutical preparation, preparation method therefor and use thereof29 Sep 2026US 12,746,241 B2Shanghai Haiyan Pharmaceutical Technology Co., Ltd.
- Methods and compositions for interfering with extraction or conversion of a drug susceptible to abuse22 Sep 2026US 12,740,948 B2Acura Pharmaceuticals, Inc.
- Drug-polymer amorphous solid dispersions using linear polyacrylic acid polymers8 Oct 2026US 2026/0306410 A1Lubrizol Advanced Materials, Inc.
- Pharmaceutical oral dosage form of q2038 Oct 2026US 2026/0306411 A1Qurient Co., Ltd.
- Colonic purgative tablet and colonic purgative comprising same8 Oct 2026US 2026/0306413 A1Pharmbio Korea Co., Ltd.
- Compounds and combinations thereof for treating neurological and psychiatric conditions8 Oct 2026US 2026/0306426 A1Antecip Bioventures II LLC
- Method and pharmaceutical composition for treating a sleep disorder8 Oct 2026US 2026/0306442 A1Overseas Pharmaceuticals, Ltd.
Most cited
By later US patents
- Temperature-controlled active agent dispenser1,474US 4,830,855 ALandec Labs, Inc. · 1989
- Methods of using in situ hydration of hydrogel articles for sealing or augmentation of tissue or vessels548US 6,605,294 B2Incept, LLC · 2003
- Controlled release oxycodone compositions466US 5,508,042 AEuro-Celtigue, S.A. · 1996
- Controlled release oxycodone compositions436US 5,266,331 AEuroceltique, S.A. · 1993
- Controlled release oxycodone compositions411US 5,549,912 AEuro-Celtique S. A. · 1996